HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adam Linder Selected Research

Biomarkers (Surrogate Marker)

1/2022The Dynamics of Circulating Heparin-Binding Protein: Implications for Its Use as a Biomarker.
6/2021Heparin-binding protein in lower airway samples as a biomarker for pneumonia.
1/2021Heparin binding protein in severe COVID-19-A prospective observational cohort study.
9/2020Repeated measures of Heparin-binding protein (HBP) and procalcitonin during septic shock: biomarker kinetics and association with cardiovascular organ dysfunction.
1/2020Scores for sepsis detection and risk stratification - construction of a novel score using a statistical approach and validation of RETTS.
12/2019Heparin-Binding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency Department.
7/2019NEWS2 is Superior to qSOFA in Detecting Sepsis with Organ Dysfunction in the Emergency Department.
10/2017Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury.
1/2017Infectious complications after out-of-hospital cardiac arrest-A comparison between two target temperatures.
1/2017Heparin-Binding Protein (HBP): A Causative Marker and Potential Target for Heparin Treatment of Human Sepsis-Induced Acute Kidney Injury.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adam Linder Research Topics

Disease

29Sepsis (Septicemia)
01/2022 - 07/2009
19Infections
08/2021 - 08/2008
11Septic Shock (Toxic Shock Syndrome)
09/2020 - 10/2009
6Shock
06/2022 - 10/2009
5Inflammation (Inflammations)
12/2021 - 11/2014
5Bacterial Meningitis
11/2021 - 04/2011
5Bacterial Infections (Bacterial Infection)
04/2020 - 01/2010
5Acute Kidney Injury (Acute Renal Failure)
01/2020 - 11/2016
4Critical Illness (Critically Ill)
02/2016 - 07/2013
3Meningitis
10/2021 - 08/2020
3COVID-19
01/2021 - 01/2020
3Urinary Tract Infections (Urinary Tract Infection)
06/2016 - 08/2012
3Erysipelas
05/2014 - 05/2010
2Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
10/2021 - 10/2019
2Pneumonia (Pneumonitis)
06/2021 - 01/2017
2Heart Arrest (Cardiac Arrest)
01/2017 - 07/2013
2Necrotizing Fasciitis
12/2015 - 01/2014
2Soft Tissue Infections
01/2014 - 08/2008
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
12/2012 - 01/2010
1Hypersensitivity (Allergy)
11/2021
1Hearing Loss (Hearing Impairment)
11/2021
1Ventilator-Associated Pneumonia
06/2021
1Hemorrhage
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Tick-Borne Encephalitis (Encephalitis, Tick Borne)
01/2021
1Viral Meningitis
01/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Kidney Diseases (Kidney Disease)
01/2020
1Communicable Diseases (Infectious Diseases)
01/2018
1Out-of-Hospital Cardiac Arrest
01/2017
1Lung Injury
12/2016
1Bacteriuria
06/2016
1Disease Progression
11/2015

Drug/Important Bio-Agent (IBA)

23human AZU1 proteinIBA
01/2022 - 10/2009
14Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2012
8Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2007
7Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 03/2014
4Vasopressins (Vasopressin)IBA
01/2020 - 11/2016
4Immunoglobulin G (IgG)IBA
01/2019 - 01/2007
3ProteomeIBA
01/2021 - 01/2018
3ProcalcitoninIBA
09/2020 - 11/2015
3CytokinesIBA
01/2020 - 11/2016
3AntibodiesIBA
01/2019 - 01/2007
3Indicators and Reagents (Reagents)IBA
11/2015 - 10/2009
2Heparin (Liquaemin)FDA LinkGeneric
11/2021 - 01/2017
2Deoxyribonucleases (DNase)FDA Link
10/2021 - 01/2021
2Deoxyribonuclease I (Nickase)IBA
10/2021 - 10/2019
2Biological ProductsIBA
12/2018 - 07/2014
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2018 - 11/2016
2EnzymesIBA
01/2018 - 01/2010
2C-Reactive ProteinIBA
01/2017 - 11/2015
2LipopolysaccharidesIBA
12/2016 - 11/2014
2Apolipoproteins MIBA
01/2016 - 12/2012
2Histones (Histone)IBA
12/2015 - 01/2014
2Chemotactic FactorsIBA
12/2015 - 01/2010
1Urokinase Plasminogen Activator ReceptorsIBA
12/2021
1Succinic Acid (Succinate)IBA
11/2021
1Flavin Mononucleotide (FMN)IBA
11/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021
1Immunoglobulins (Immunoglobulin)IBA
11/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
11/2021
1InosineFDA Link
11/2021
1Niacinamide (Nicotinamide)FDA LinkGeneric
11/2021
1Pentoxifylline (Trental)FDA LinkGeneric
11/2021
1Oxygen (Dioxygen)IBA
01/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1dornase alfa (Pulmozyme)FDA Link
01/2021
1AntithrombinsIBA
12/2019
1Protein Isoforms (Isoforms)IBA
12/2019
1GlypicansIBA
01/2019
1Polysaccharides (Glycans)IBA
01/2019
1VaccinesIBA
01/2019
1Proprotein Convertase 9IBA
12/2018
1insulin receptor-related receptor (IRR)IBA
12/2018
1AlbuminsIBA
01/2018
1Serum AlbuminIBA
01/2018
1ThrombinFDA Link
01/2018
1Angiopoietin-1IBA
11/2016
1Angiopoietin-2IBA
11/2016
1Interleukin-6 (Interleukin 6)IBA
06/2016
1ResistinIBA
02/2016
1Carrier Proteins (Binding Protein)IBA
01/2016
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1LipidsIBA
01/2016
1Lactic Acid (Lactate)FDA LinkGeneric
11/2015
1EndotoxinsIBA
11/2014

Therapy/Procedure

8Therapeutics
06/2022 - 08/2014
5Critical Care (Surgical Intensive Care)
08/2021 - 07/2019
3Renal Replacement Therapy (Therapies, Renal Replacement)
01/2018 - 01/2016
2Lithotripsy (Extracorporeal Shockwave Lithotripsy)
06/2022 - 04/2020
1Injections
10/2021
1Length of Stay
05/2021
1Aftercare (After-Treatment)
01/2021
1Antibiotic Prophylaxis
04/2020
1Fluid Therapy (Oral Rehydration Therapy)
01/2020
1Noninvasive Ventilation
01/2020
1Intravenous Injections
12/2016